News
30.09.2015
8-11 September 2015 RUE "Belmedpreparaty" participated in the "21-th International specialized exhibition MOLDMEDIZIN & MOLDDENT in the Republic of Moldova. The exhibition united the leading manufacturers and distributors of medicines, medical and dental equipment, instruments, as well as doctors, pharmacists, representatives of the business community from Moldova, Belarus, Pakistan, Russia, Romania and Ukraine. During the exhibition members of RUE "Belmedpreparaty" were presented drug products of different pharmacological groups: antineoplastic agents, antibiotics, antithrombotic agents,
products for treatment of cardiovascular and nervous systems diseases,
products for treatment of musculo-skeletal system diseases.
Special attention was paid to antineoplastic drug products due to the fact that RUE "Belmedpreparaty" is a leader of production of this kind of products.
During the visit to the Republic of Moldova negotiations with representatives of the Moldovan pharmaceutical companies were held. Issues on cooperation in the sphere of registration and supplies of medicines were discussed.
18.06.2013
RUE "Belmedpreparaty" participate at the 14th World Conference of the International Photodynamic Association.
Despite achievements in surgery, the use of advanced equipment for radiotherapy, as well as the availability of variety methods of chemotherapy, the traditional methods of
treatment cancer patients cannot fully meet the requirements of clinical practice. Each method has its own advantages, disadvantages and limitations. All this encourages specialists all
over the world to find new ways in diagnosis and treatment of cancer patients. One of these new methods, which has shown promising results in recent years, is photodynamic therapy (PDT).
Its action is based on the accumulation of the drug in the tumor - photo sensitizer, which under the influence of laser light with the presence of oxygen generates cytotoxic agent.
These substances are allocated during photo irradiation. They initiate a chain of biochemical reactions which inactivate cell malignancies.
This method of treatment allows to destroy tumor tissue without significant damage to healthy tissue and without intoxication of the patient organism.
The main advantages of PDT method over conventional methods of cancer treatment are selective destruction of tumor, absence of severe systemic complications,
the permissibility of multiple repetition, combination of fluorescent diagnostics and therapeutic effects in a single procedure, low cost of treatment. In most cases,
photodynamic therapy - a non-invasive or minimally invasive treatment method for human organs. In many countries today, scientists and clinicians engaged in research
aimed at the development of new and optimization of existing PDT regimes of malignant tumors with different morphological types and locations, as well as the creation of new,
more safe and effective photo sensitizers. Successful development and widespread adoption of PDT in the treatment of cancer determines the growing interest of researchers to the
possibilities of using this method in other areas of medicine, including ophthalmology, dentistry, purulent surgery etc.
28.05.2013
Within the period from May 23 to May 25, RUE "Belmedpreparaty" took part in the Belarusian-Russian scientific-practical conference "Domestic antitumor drugs"
with international participation.
RUE "Belmedpreparaty" has acted as the general sponsor and one of the organizers of the conference along with the Belarussian State University,
Federal State Institution “Russian Oncology named after NN Blohin Scientific Center", Republican Scientific-Practical Center of Oncology and Medical Radiology named
after N.N.Aleksandrov, Institute of physico-chemical problems BSU, BSU enterprises "Unitechprom" and "Unidragmet", the Institute of Bioorganic chemistry of
The National Academy of Sciences of Belarus, Institute of organic synthesis named after I. A. Postovsky Ural Branch of the Russian Academy of Sciences.
10.12.2012
November 29, 2012 The Deputy of General director of the World Intellectual Property Organization (WIPO, Switzerland), Mr. Yo Takagi
awarded the highest award - the Gold Medal for RUE "Belmedpreparaty" - the best innovative company. While presenting the award, Mr. Yo Takagi said that "
Belmedpreparaty" was awarded the medal for creation of intellectual property and sustainable management. At present RUE "Belmedpreparaty"
owns 93 patents and 205 certificates for trademarks. About half of the patents now are used in the production of highly effective medicines.
RUE "Belmedpreparaty" is the first and the only enterprise in the country to be awarded such a high mark of the World Intellectual Property Organization,
working with the UN.
29.06.2011
July 3 - Independence Day (Day of the Republic)
Congratulations to all employees on a holiday!
We wish you, dear colleagues and friends, good health, prosperity, love, new, creative and successful work.
Administration, Trade Union
15.06.2011
June 19 - Day of Healthcare professional
Congratulations to all Healthcare professional on their holiday!
We wish you, dear colleagues and friends, good health, happiness, fruitful activity for the benefit of all people of our country, realization of tasks, effort and patience to overcome any difficulties.
Administration, Trade Union
09.04.2011
News
In the period from March 29 to April 1, 2011 in the capital's football arena held XVIII International Exhibition "Healthcare of Belarus - 2011".
24.02.2011
News
Achievements and recognition
RUE "Belmedpreparaty" has been awarded with Honorary Diploma of the Minsk city executive committee.
09.02.2011
News
Cooperation
RUE "Belmedpreparaty" collaborates with leading research centers of the republic, near and far abroad.
03.02.2011
News
Today RUE "Belmedpreparaty" was visited by the Deputy Prime Minister of the Republic of Belarus A. Tozik. Deputy Prime Minister was informed about the work of the main production facilities of RUE "Belmedpreparaty", He visited tablet production site and manufacturing of solutions for injection (insulin), as well as R&D departments.
1 | 2 ›
»